Works matching IS 10538569 AND DT 2025 AND VI 34 AND IP 3
Results: 13
Comment on: "Evaluating the Accuracy of Responses by Large Language Models for Information on Disease Epidemiology".
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70137
- By:
- Publication type:
- Article
Effect of Deregulation of the Brazilian National Controlled Products Management System on Antidepressants' Sales Data Deregulation of a Brazilian Drug Electronic System.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70136
- By:
- Publication type:
- Article
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70135
- By:
- Publication type:
- Article
Ten Must‐Read Papers on Transparency and Reproducibility in Pharmacoepidemiology.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70119
- By:
- Publication type:
- Article
A Brief Report on Proposed Areas of International Harmonization of Real‐World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70127
- By:
- Publication type:
- Article
A Comparative Real‐World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70124
- By:
- Publication type:
- Article
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70123
- By:
- Publication type:
- Article
Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID‐19 Adenovirus Vector Vaccines: Comment.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70122
- By:
- Publication type:
- Article
High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐Converting Enzyme Inhibitor Initiators.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70132
- By:
- Publication type:
- Article
Real‐World Data and Real‐World Evidence in Regulatory Decision Making: Report Summary From the Council for International Organizations of Medical Sciences (CIOMS) Working Group XIII.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70117
- By:
- Publication type:
- Article
Development of an Adverse Event Reporting Form for Herbal Medicine: A Delphi Expert Consensus Study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70116
- By:
- Publication type:
- Article
Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Deliveries Identified From Inpatient Versus Outpatient Claims.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70115
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.5825
- Publication type:
- Article